Janssen Pharmaceutica notifies health professionals of the
market withdrawal >of Propulsid as of July 14, 2000 due to the risk of
serious cardiac >arrythmias and death associated with the use of Propulsid
in certain >patients. Propulsid will be available through an
investigational limited >access program. A copy of the letter may be
found at: >http://www.fda.gov/medwatch/safety/2000/safety00.htm#propul
